ID   FOXN1_HUMAN             Reviewed;         648 AA.
AC   O15353; B2R9Q7; O15352;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   28-JUN-2023, entry version 189.
DE   RecName: Full=Forkhead box protein N1;
DE   AltName: Full=Winged-helix transcription factor nude;
GN   Name=FOXN1; Synonyms=RONU, WHN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT VAL-283.
RC   TISSUE=Thymus;
RX   PubMed=9321431; DOI=10.1007/s002510050312;
RA   Schorpp M., Hofmann M., Dear T.N., Boehm T.;
RT   "Characterization of mouse and human nude genes.";
RL   Immunogenetics 46:509-515(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   INVOLVEMENT IN TIDAND, AND VARIANT TIDAND 255-ARG--ALA-648 DEL.
RX   PubMed=10206641; DOI=10.1038/18997;
RA   Frank J., Pignata C., Panteleyev A.A., Prowse D.M., Baden H., Weiner L.,
RA   Gaetaniello L., Ahmad W., Pozzi N., Cserhalmi-Friedman P.B., Aita V.M.,
RA   Uyttendaele H., Gordon D., Ott J., Brissette J.L., Christiano A.M.;
RT   "Exposing the human nude phenotype.";
RL   Nature 398:473-474(1999).
RN   [5]
RP   FUNCTION, INVOLVEMENT IN TIDAND, AND VARIANT TIDAND 255-ARG--ALA-648 DEL.
RX   PubMed=21507891; DOI=10.1136/jmg.2011.089532;
RA   Vigliano I., Gorrese M., Fusco A., Vitiello L., Amorosi S., Panico L.,
RA   Ursini M.V., Calcagno G., Racioppi L., Del Vecchio L., Pignata C.;
RT   "FOXN1 mutation abrogates prenatal T-cell development in humans.";
RL   J. Med. Genet. 48:413-416(2011).
RN   [6]
RP   INVOLVEMENT IN TIDAND.
RX   PubMed=25173801; DOI=10.1016/j.clim.2014.08.005;
RA   Chou J., Massaad M.J., Wakim R.H., Bainter W., Dbaibo G., Geha R.S.;
RT   "A novel mutation in FOXN1 resulting in SCID: a case report and literature
RT   review.";
RL   Clin. Immunol. 155:30-32(2014).
RN   [7]
RP   REVIEW.
RX   PubMed=23874334; DOI=10.3389/fimmu.2013.00187;
RA   Romano R., Palamaro L., Fusco A., Giardino G., Gallo V., Del Vecchio L.,
RA   Pignata C.;
RT   "FOXN1: a master regulator gene of thymic epithelial development program.";
RL   Front. Immunol. 4:187-187(2013).
RN   [8]
RP   REVIEW.
RX   PubMed=24432845; DOI=10.3109/08830185.2013.870171;
RA   Palamaro L., Romano R., Fusco A., Giardino G., Gallo V., Pignata C.;
RT   "FOXN1 in organ development and human diseases.";
RL   Int. Rev. Immunol. 33:83-93(2014).
RN   [9]
RP   VARIANTS TIDAND 255-ARG--ALA-648 DEL AND TRP-320.
RX   PubMed=20978268; DOI=10.1182/blood-2010-06-292490;
RA   Markert M.L., Marques J.G., Neven B., Devlin B.H., McCarthy E.A.,
RA   Chinn I.K., Albuquerque A.S., Silva S.L., Pignata C., de Saint Basile G.,
RA   Victorino R.M., Picard C., Debre M., Mahlaoui N., Fischer A., Sousa A.E.;
RT   "First use of thymus transplantation therapy for FOXN1 deficiency
RT   (nude/SCID): a report of 2 cases.";
RL   Blood 117:688-696(2011).
RN   [10]
RP   VARIANT TIDAND 255-ARG--ALA-648 DEL.
RX   PubMed=28636882; DOI=10.1016/j.gene.2017.06.033;
RA   Radha Rama Devi A., Panday N.N., Naushad S.M.;
RT   "FOXN1 Italian founder mutation in Indian family: Implications in prenatal
RT   diagnosis.";
RL   Gene 627:222-225(2017).
RN   [11]
RP   VARIANTS TLIND LYS-169; 255-ARG--ALA-648 DEL; TRP-320; ASN-321; PRO-325 AND
RP   474-GLN--ALA-648 DEL, AND INVOLVEMENT IN TLIND.
RX   PubMed=31447097; DOI=10.1016/j.ajhg.2019.07.014;
RA   Bosticardo M., Yamazaki Y., Cowan J., Giardino G., Corsino C., Scalia G.,
RA   Prencipe R., Ruffner M., Hill D.A., Sakovich I., Yemialyanava I., Tam J.S.,
RA   Padem N., Elder M.E., Sleasman J.W., Perez E., Niebur H., Seroogy C.M.,
RA   Sharapova S., Gebbia J., Kleiner G.I., Peake J., Abbott J.K., Gelfand E.W.,
RA   Crestani E., Biggs C., Butte M.J., Hartog N., Hayward A., Chen K.,
RA   Heimall J., Seeborg F., Bartnikas L.M., Cooper M.A., Pignata C.,
RA   Bhandoola A., Notarangelo L.D.;
RT   "Heterozygous FOXN1 variants cause low TRECs and severe T cell lymphopenia,
RT   revealing a crucial role of FOXN1 in supporting early thymopoiesis.";
RL   Am. J. Hum. Genet. 105:549-561(2019).
RN   [12]
RP   VARIANT TIDTA 363-TRP--PRO-368 DELINS CYS, INVOLVEMENT IN TIDTA, VARIANTS
RP   SER-242 AND SER-430, CHARACTERIZATION OF VARIANT TIDTA 363-TRP--PRO-368
RP   DELINS CYS, CHARACTERIZATION OF VARIANTS SER-242 AND SER-430, AND
RP   CHARACTERIZATION OF VARIANT TIDAND TRP-320.
RX   PubMed=31566583; DOI=10.1172/jci127565;
RA   Du Q., Huynh L.K., Coskun F., Molina E., King M.A., Raj P., Khan S.,
RA   Dozmorov I., Seroogy C.M., Wysocki C.A., Padron G.T., Yates T.R.,
RA   Markert M.L., de la Morena M.T., van Oers N.S.;
RT   "FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in
RT   humans.";
RL   J. Clin. Invest. 129:4724-4738(2019).
CC   -!- FUNCTION: Transcriptional regulator which regulates the development,
CC       differentiation, and function of thymic epithelial cells (TECs) both in
CC       the prenatal and postnatal thymus. Acts as a master regulator of the
CC       TECs lineage development and is required from the onset of
CC       differentiation in progenitor TECs in the developing fetus to the final
CC       differentiation steps through which TECs mature to acquire their full
CC       functionality. Regulates, either directly or indirectly the expression
CC       of a variety of genes that mediate diverse aspects of thymus
CC       development and function, including MHC Class II, DLL4, CCL25, CTSL,
CC       CD40 and PAX1. Regulates the differentiation of the immature TECs into
CC       functional cortical TECs (cTECs) and medullary TECs (mTECs). Essential
CC       for maintenance of mTECs population in the postnatal thymus. Involved
CC       in the morphogenesis and maintenance of the three-dimensional thymic
CC       microstructure which is necessary for a fully functional thymus. Plays
CC       an important role in the maintenance of hematopoiesis and particularly
CC       T lineage progenitors within the bone marrow niche with age. Essential
CC       for the vascularization of the thymus anlage. Promotes the terminal
CC       differentiation of epithelial cells in the epidermis and hair
CC       follicles, partly by negatively regulating the activity of protein
CC       kinase C (By similarity). Plays a crucial role in the early prenatal
CC       stages of T-cell ontogeny (PubMed:21507891).
CC       {ECO:0000250|UniProtKB:Q61575, ECO:0000269|PubMed:21507891}.
CC   -!- INTERACTION:
CC       O15353; P32320: CDA; NbExp=3; IntAct=EBI-11319000, EBI-9250559;
CC       O15353; Q9UJX2: CDC23; NbExp=3; IntAct=EBI-11319000, EBI-396137;
CC       O15353; Q9NQL9: DMRT3; NbExp=3; IntAct=EBI-11319000, EBI-9679045;
CC       O15353; P49639: HOXA1; NbExp=3; IntAct=EBI-11319000, EBI-740785;
CC       O15353; Q68G74: LHX8; NbExp=3; IntAct=EBI-11319000, EBI-8474075;
CC       O15353; O60336: MAPKBP1; NbExp=3; IntAct=EBI-11319000, EBI-947402;
CC       O15353; Q13526: PIN1; NbExp=3; IntAct=EBI-11319000, EBI-714158;
CC       O15353; Q9H0A9-2: SPATC1L; NbExp=3; IntAct=EBI-11319000, EBI-11995806;
CC       O15353; Q08117-2: TLE5; NbExp=3; IntAct=EBI-11319000, EBI-11741437;
CC       O15353; Q12933: TRAF2; NbExp=3; IntAct=EBI-11319000, EBI-355744;
CC       O15353; O75865-2: TRAPPC6A; NbExp=3; IntAct=EBI-11319000, EBI-8451480;
CC       O15353; Q9BXA7: TSSK1B; NbExp=4; IntAct=EBI-11319000, EBI-6423734;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in thymus.
CC   -!- DISEASE: T-cell immunodeficiency, congenital alopecia, and nail
CC       dystrophy (TIDAND) [MIM:601705]: A disorder characterized by the
CC       association of congenital alopecia, severe T-cell immunodeficiency, and
CC       ridging and pitting of all nails. {ECO:0000269|PubMed:10206641,
CC       ECO:0000269|PubMed:20978268, ECO:0000269|PubMed:21507891,
CC       ECO:0000269|PubMed:25173801, ECO:0000269|PubMed:28636882,
CC       ECO:0000269|PubMed:31566583}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: T-cell lymphopenia, infantile, with or without nail dystrophy,
CC       autosomal dominant (TLIND) [MIM:618806]: An autosomal dominant disorder
CC       characterized by decreased numbers of T cells, particularly cytotoxic
CC       CD8+ T cells, and increased susceptibility to recurrent infections,
CC       mainly respiratory viral infections. Additional features may include
CC       impaired thymic development, skin abnormalities, such as atopic
CC       dermatitis, and nail dystrophy. {ECO:0000269|PubMed:31447097}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: T-cell immunodeficiency with thymic aplasia (TIDTA)
CC       [MIM:242700]: An autosomal recessive disorder characterized by
CC       selective hypo- or aplasia of the thymus, T-cell immunodeficiency due
CC       to impaired T-cell development, and increased susceptibility to viral
CC       infections. {ECO:0000269|PubMed:31566583}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=FOXN1base; Note=FOXN1 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/FOXN1base/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y11741; CAA72417.1; -; Genomic_DNA.
DR   EMBL; Y11742; CAA72417.1; JOINED; Genomic_DNA.
DR   EMBL; Y11743; CAA72417.1; JOINED; Genomic_DNA.
DR   EMBL; Y11744; CAA72417.1; JOINED; Genomic_DNA.
DR   EMBL; Y11745; CAA72417.1; JOINED; Genomic_DNA.
DR   EMBL; Y11746; CAA72417.1; JOINED; Genomic_DNA.
DR   EMBL; Y11739; CAA72416.1; -; mRNA.
DR   EMBL; AK313878; BAG36604.1; -; mRNA.
DR   EMBL; CH471159; EAW51092.1; -; Genomic_DNA.
DR   CCDS; CCDS11232.1; -.
DR   RefSeq; NP_003584.2; NM_003593.2.
DR   RefSeq; XP_005258103.1; XM_005258046.3.
DR   PDB; 5OCN; X-ray; 2.70 A; A/B/C/D/E/F/G/H=270-366.
DR   PDB; 6EL8; X-ray; 1.61 A; A/D=270-366.
DR   PDBsum; 5OCN; -.
DR   PDBsum; 6EL8; -.
DR   AlphaFoldDB; O15353; -.
DR   SMR; O15353; -.
DR   BioGRID; 114034; 38.
DR   IntAct; O15353; 36.
DR   MINT; O15353; -.
DR   STRING; 9606.ENSP00000226247; -.
DR   iPTMnet; O15353; -.
DR   PhosphoSitePlus; O15353; -.
DR   BioMuta; FOXN1; -.
DR   jPOST; O15353; -.
DR   MassIVE; O15353; -.
DR   MaxQB; O15353; -.
DR   PaxDb; O15353; -.
DR   PeptideAtlas; O15353; -.
DR   ProteomicsDB; 48606; -.
DR   Antibodypedia; 14085; 304 antibodies from 36 providers.
DR   DNASU; 8456; -.
DR   Ensembl; ENST00000226247.2; ENSP00000226247.2; ENSG00000109101.8.
DR   Ensembl; ENST00000577936.2; ENSP00000462159.2; ENSG00000109101.8.
DR   Ensembl; ENST00000579795.6; ENSP00000464645.1; ENSG00000109101.8.
DR   GeneID; 8456; -.
DR   KEGG; hsa:8456; -.
DR   MANE-Select; ENST00000579795.6; ENSP00000464645.1; NM_001369369.1; NP_001356298.1.
DR   UCSC; uc002hbj.4; human.
DR   AGR; HGNC:12765; -.
DR   CTD; 8456; -.
DR   DisGeNET; 8456; -.
DR   GeneCards; FOXN1; -.
DR   HGNC; HGNC:12765; FOXN1.
DR   HPA; ENSG00000109101; Group enriched (esophagus, lymphoid tissue, skin, vagina).
DR   MalaCards; FOXN1; -.
DR   MIM; 242700; phenotype.
DR   MIM; 600838; gene.
DR   MIM; 601705; phenotype.
DR   MIM; 618806; phenotype.
DR   neXtProt; NX_O15353; -.
DR   OpenTargets; ENSG00000109101; -.
DR   Orphanet; 169095; Severe combined immunodeficiency due to FOXN1 deficiency.
DR   PharmGKB; PA37368; -.
DR   VEuPathDB; HostDB:ENSG00000109101; -.
DR   eggNOG; KOG2294; Eukaryota.
DR   GeneTree; ENSGT00940000158029; -.
DR   HOGENOM; CLU_031768_1_0_1; -.
DR   InParanoid; O15353; -.
DR   OMA; YCSSHPF; -.
DR   OrthoDB; 5385885at2759; -.
DR   PhylomeDB; O15353; -.
DR   TreeFam; TF329867; -.
DR   PathwayCommons; O15353; -.
DR   SignaLink; O15353; -.
DR   SIGNOR; O15353; -.
DR   BioGRID-ORCS; 8456; 15 hits in 1169 CRISPR screens.
DR   ChiTaRS; FOXN1; human.
DR   GeneWiki; FOXN1; -.
DR   GenomeRNAi; 8456; -.
DR   Pharos; O15353; Tbio.
DR   PRO; PR:O15353; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; O15353; protein.
DR   Bgee; ENSG00000109101; Expressed in gingival epithelium and 58 other tissues.
DR   ExpressionAtlas; O15353; baseline and differential.
DR   Genevisible; O15353; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IBA:GO_Central.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0048514; P:blood vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0006952; P:defense response; TAS:ProtInc.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0001942; P:hair follicle development; IEA:Ensembl.
DR   GO; GO:0030216; P:keratinocyte differentiation; IEA:Ensembl.
DR   GO; GO:0097535; P:lymphoid lineage cell migration into thymus; IEA:Ensembl.
DR   GO; GO:0035878; P:nail development; IEA:Ensembl.
DR   GO; GO:0030858; P:positive regulation of epithelial cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0051798; P:positive regulation of hair follicle development; IEA:Ensembl.
DR   GO; GO:1902232; P:regulation of positive thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0043029; P:T cell homeostasis; IEA:Ensembl.
DR   GO; GO:0002360; P:T cell lineage commitment; IEA:Ensembl.
DR   GO; GO:0097536; P:thymus epithelium morphogenesis; IEA:Ensembl.
DR   CDD; cd20056; FH_FOXN1; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR047401; FH_FOXN1.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR030456; TF_fork_head_CS_2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR46721; FORKHEAD BOX PROTEIN N1; 1.
DR   PANTHER; PTHR46721:SF1; FORKHEAD BOX PROTEIN N1; 1.
DR   Pfam; PF00250; Forkhead; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00658; FORK_HEAD_2; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Developmental protein; Differentiation; Disease variant;
KW   DNA-binding; Hypotrichosis; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..648
FT                   /note="Forkhead box protein N1"
FT                   /id="PRO_0000091866"
FT   DNA_BIND        271..367
FT                   /note="Fork-head"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00089"
FT   REGION          1..105
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          392..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          458..508
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          623..648
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        42..56
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        405..435
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VARIANT         69
FT                   /note="R -> C (in dbSNP:rs2071587)"
FT                   /id="VAR_020025"
FT   VARIANT         169
FT                   /note="E -> K (in TLIND; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31447097"
FT                   /id="VAR_083857"
FT   VARIANT         242
FT                   /note="P -> S (does not affect transcriptional activity as
FT                   shown by a transcriptional reporter assay;
FT                   dbSNP:rs140921495)"
FT                   /evidence="ECO:0000269|PubMed:31566583"
FT                   /id="VAR_083858"
FT   VARIANT         255..648
FT                   /note="Missing (in TIDAND and TLIND)"
FT                   /evidence="ECO:0000269|PubMed:10206641,
FT                   ECO:0000269|PubMed:20978268, ECO:0000269|PubMed:21507891,
FT                   ECO:0000269|PubMed:28636882, ECO:0000269|PubMed:31447097"
FT                   /id="VAR_083859"
FT   VARIANT         283
FT                   /note="A -> V"
FT                   /evidence="ECO:0000269|PubMed:9321431"
FT                   /id="VAR_010376"
FT   VARIANT         320
FT                   /note="R -> W (in TIDAND and TLIND; severely reduced
FT                   transcriptional activity as shown by a transcriptional
FT                   reporter assay; dbSNP:rs1288977950)"
FT                   /evidence="ECO:0000269|PubMed:20978268,
FT                   ECO:0000269|PubMed:31447097, ECO:0000269|PubMed:31566583"
FT                   /id="VAR_083860"
FT   VARIANT         321
FT                   /note="H -> N (in TLIND; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31447097"
FT                   /id="VAR_083861"
FT   VARIANT         325
FT                   /note="L -> P (in TLIND; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31447097"
FT                   /id="VAR_083862"
FT   VARIANT         363..368
FT                   /note="WKRKDP -> C (in TIDTA; decreased transcriptional
FT                   activity as shown by a transcriptional reporter assay)"
FT                   /evidence="ECO:0000269|PubMed:31566583"
FT                   /id="VAR_083863"
FT   VARIANT         411
FT                   /note="R -> W (in dbSNP:rs2286520)"
FT                   /id="VAR_021843"
FT   VARIANT         430
FT                   /note="P -> S (does not affect transcriptional activity as
FT                   shown by a transcriptional reporter assay;
FT                   dbSNP:rs61749867)"
FT                   /evidence="ECO:0000269|PubMed:31566583"
FT                   /id="VAR_083864"
FT   VARIANT         474..648
FT                   /note="Missing (in TLIND)"
FT                   /evidence="ECO:0000269|PubMed:31447097"
FT                   /id="VAR_083865"
FT   VARIANT         599
FT                   /note="A -> P (in dbSNP:rs532648)"
FT                   /id="VAR_020026"
FT   HELIX           276..285
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   STRAND          287..293
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   HELIX           294..304
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   HELIX           307..310
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   HELIX           315..325
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   STRAND          329..332
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   STRAND          345..348
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   HELIX           350..352
FT                   /evidence="ECO:0007829|PDB:6EL8"
FT   HELIX           353..360
FT                   /evidence="ECO:0007829|PDB:6EL8"
SQ   SEQUENCE   648 AA;  68925 MW;  F32F4C95627E60DE CRC64;
     MVSLPPPQSD VTLPGPTRLE GERQGDLMQA PGLPGSPAPQ SKHAGFSCSS FVSDGPPERT
     PSLPPHSPRI ASPGPEQVQG HCPAGPGPGP FRLSPSDKYP GFGFEEAAAS SPGRFLKGSH
     APFHPYKRPF HEDVFPEAET TLALKGHSFK TPGPLEAFEE IPVDVAEAEA FLPGFSAEAW
     CNGLPYPSQE HGPQVLGSEV KVKPPVLESG AGMFCYQPPL QHMYCSSQPP FHQYSPGGGS
     YPIPYLGSSH YQYQRMAPQA STDGHQPLFP KPIYSYSILI FMALKNSKTG SLPVSEIYNF
     MTEHFPYFKT APDGWKNSVR HNLSLNKCFE KVENKSGSSS RKGCLWALNP AKIDKMQEEL
     QKWKRKDPIA VRKSMAKPEE LDSLIGDKRE KLGSPLLGCP PPGLSGSGPI RPLAPPAGLS
     PPLHSLHPAP GPIPGKNPLQ DLLMGHTPSC YGQTYLHLSP GLAPPGPPQP LFPQPDGHLE
     LRAQPGTPQD SPLPAHTPPS HSAKLLAEPS PARTMHDTLL PDGDLGTDLD AINPSLTDFD
     FQGNLWEQLK DDSLALDPLV LVTSSPTSSS MPPPQPPPHC FPPGPCLTET GSGAGDLAAP
     GSGGSGALGD LHLTTLYSAF MELEPTPPTA PAGPSVYLSP SSKPVALA
//
